ClinicalTrials.gg
RecruitingNCT06402448Updated May 7, 2024

Prevalence of Muscle and Nerve and Joint Pain

An observational study in Muscle Pain, Joint Pain and Nerve Pain, sponsored by Hadeer Gomaa Ebraheem Aly. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2024-05-07.

Sponsored by Hadeer Gomaa Ebraheem Aly · Observational

From the registry’s dates

  • Primary completion was expected by May 2024, 2 years 6 months ago, but the record still lists the study as recruiting.
  • Started Feb 2024; still recruiting 2 years 9 months later.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
300
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The purpose of the study is to provide adequate information about the percentage of the main tissue that causing pain in most common spinal disorders either it is muscular, nerve or joint in each spinal parts, that will provide the physical therapist with large data that can be helpful in differential diagnosis.

02

Conditions studied

  • Muscle Pain
  • Joint Pain
  • Nerve Pain
03

In context

Myalgia

256 studies on the registry are indexed under Myalgia; 46 are open to participants now.

This study's planned enrollment of 300 is above the median of 196 across 35 observational studies indexed under Myalgia.

Browse Myalgia studies →

Lead sponsor

This is the only study on the registry with Hadeer Gomaa Ebraheem Aly as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

patients from 18 to 6o years , both gender and any condition diagnosed by orthopedic physician with spinal disorders and pre and post operative patient may be included.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • patients from 18 to 60years
    • both gender and any condition diagnosed by orthopedic physician with spinal disorders
    • pre and post operative patient may be included.

Exclusion criteria

Exclusion Criteria:

  1. viscerogenic pain
  2. cancer
  3. psychogenic pain or psychogenic disorder
  4. rheumatoid arthritis
  5. fibromyalgia.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
300 participants (estimated)
Patient registry
No

Groups and cohorts

  • group 1

    one group containing 300 patients of muscle , joint and nerve pain.

    Diagnostic Test: muscle pain , joint pain and nerve pain.

Interventions

  • Diagnostic testmuscle pain , joint pain and nerve pain.

    to discover the percentage of each tissue that causing pain even it is muscle, joint or nerve in patients with spinal disorders.

06

What researchers measure

Primary outcomes

  1. muscle pain

    muscle pain with pressure algometer ,stretch and resisted range of motion .

    Time frame: 5 months

  2. joint pain

    joint pain with joint play and physiological range of motion .

    Time frame: 5 months

  3. nerve pain

    nerve pain with tinel sign and neural tension test .

    Time frame: 5 months

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Feb 2024 (actual). Primary completion is estimated for May 2024, 3 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 19, 2024
First posted
May 7, 2024
StartActual
Feb 1, 2024
Primary completionEst.
May 2024
CompletionEst.
Jul 2024
Last update
May 7, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 7, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06402448
Lead sponsor
Hadeer Gomaa Ebraheem Aly
Responsible party
Hadeer Gomaa Ebraheem Aly (physiotherapist, Cairo University) — Sponsor-investigator
First posted
May 7, 2024
Start date
Feb 1, 2024
Primary completion
May 2024 (estimated)
Completion
Jul 2024 (estimated)
Last update
May 7, 2024

Study contacts

Hadeer Gomaa Ebraheem, bachelor of physical therapy
Contact
drhadeer25aly@gmail.com
01030759201

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion